The current share price of Cipla is ₹1,506.30, with a market capitalization of ₹1,22,283.61. The stock is currently trading at the P/E ratio of 22.68x and it has a Debt/Equity ratio of 0.01x.
In Jun 2025, the company announced sales of ₹6,957.00 and net profit of ₹1,292.00. TTM ROE stands at 16.90% with promoter holding of 29.19%.
Cipla Limited is an India-based company, which is primarily engaged in the business of pharmaceuticals. The Company operates through two segments: Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. The Company's product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, the United States, South Africa, and Rest of the World. The Company has its network of manufacturing, trading and other incidental operations in India and International markets. The Company has approximately 47 manufacturing sites.
Fundamentals
Key Metrics
Profitability Ratios
Liquidity Ratios
Valuation Ratios
Solvency Ratios
Dividend Metrics
Technicals
Daily Moving Averages (DMA)
Price Trend
Price Chart
Volume Chart
Stock Returns & Corporate Actions
You can also calculate any period's returns Here..